This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: BA, MCD, HES, NFLX, DAL

Valeant Pharmaceuticals (VRX) downgraded at Piper from Overweight to Neutral, Piper Jaffray said. Valuation call, based on a $54 price target.

WellPoint (WLP) downgraded at Jefferies to Hold from Buy, Jefferies said. $72 price target. Company miss will decrease target multiple.


Boeing (BA - Get Report) estimates lowered at Citigroup through 2013, Citigroup said. Outlook for defense business is not as robust as originally forecast. Maintain Buy rating and $87 price target.

Peabody Energy (BTU) numbers lowered at Goldman. Shares of BTU now seen reaching $41, according to Goldman Sachs. Estimates also cut, given higher spending on Macarthur. Neutral rating.

Delta Air Lines (DAL - Get Report) numbers raised at UBS. Shares of DAL now seen reaching $15. Estimates also increased on strong outlook. Buy rating.

Dover (DOV) estimates, target upped at Credit Suisse. DOV estimates were boosted through 2013, Credit Suisse said. Booking are stabilizing. Neutral rating and new $67 price target.

Corning (GLW) numbers cut at UBS. Shares of GLW now seen reaching $15, according to UBS. Estimates also lowered as near term catalysts remain elusive and fundamentals remain difficult. Buy rating.

WW Grainger (GWW) numbers boosted at Goldman. Shares of GWW now seen reaching $211, Goldman Sachs said. Estimates also upped, Revenue growth is accelerating. Neutral rating.

Hess (HES - Get Report) estimates, target reduced at Goldman. HES estimates were cut through 2015, Goldman Sachs said. Company is facing higher costs. Neutral rating and new $66 price target.

Hess estimates, target lowered at UBS. Shares of HES now seen reaching $68, according to UBS. Estimates also lowered on 4Q miss and disappointing guidance. Buy rating.

Illumina (ILMN) target raised at UBS to $55 following Roche's hostile bid, UBS said. Maintain Neutral rating.

McDonald's (MCD - Get Report) estimates, target raised at BMO. Shares of MCD now seen reaching $110, according to BMO Capital. Estimates also increased, given solid comp sales momentum. Market Perform rating.

Molex (MOLX) estimates, target cut at Goldman. Shares of MOLX now seen reaching $24.50, according to Goldman Sachs. Estimates also reduced, as the company is realizing lower margins. Neutral rating.

Netflix (NFLX - Get Report) numbers raised at Oppenheimer. Shares of NFLX now seen reaching $130, Oppenheimer said. Estimates also raised on better than expected results. Outperform rating.
3 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
CVD $106.42 0.00%
ADP $88.39 -0.47%
BA $130.89 -1.21%
CHK $5.65 -2.59%
DAL $41.43 -3.47%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs